Valentina Dallacasagrande, PhD

Valentina Dallacasagrande, PhD, has a diverse work experience spanning various roles and companies. Valentina is currently employed as a Medical Director at DDB Health New York since January 2023. Prior to this, they served as a Sr. Scientific Advisor at reVision Therapeutics, Inc. starting in October 2018.

From 2015 to 2023, Valentina worked at Weill Cornell Medicine in different capacities, including Translational Scientist from April 2018 to January 2023, Postdoctoral Associate from October 2015 to March 2018, and as a finalist in the Bench to Bedside Initiative | Biotech Start-Up Pitch Competition and 100K Biomedical Business Plan Challenge | Startup Finalist in 2017-2018 at Weill Cornell Medicine BioVenture eLab.

Their earlier experience includes being a Postdoctoral Fellow at Leipzig University from April 2015 to September 2015 and a PhD candidate and Research Assistant from June 2010 to March 2015. Valentina also served as a Visiting PhD Student at the University of Cambridge in April 2013 and as a Visiting Student at Imperial College London in January 2009.

Their earliest work experience dates back to 2005 when they worked as a Sales Assistant at 3 Mobile.

Valentina Dallacasagrande, PhD, has a diverse education history in the field of biomedical engineering and biophysics. Valentina obtained a Master of Science (M.Sc.) degree in Biomedical Engineering from Politecnico di Milano, although the start and end years are not provided. Additionally, Valentina earned another Master's degree in Biomedical/Medical Engineering from the same institution, again without specified dates.

Valentina then pursued their Doctor of Philosophy (Ph.D.) in Biophysics at Leipzig University from 2010 to 2015. The focus of their doctoral research is not mentioned.

Prior to their higher education pursuits, Valentina completed their high school education at Liceo Ginnasio Melchiorre Gioia. The field of study for their high school diploma is not specified.

In terms of certifications, Valentina obtained the TOEFL certification in 2008, indicating their proficiency in English. Valentina also acquired the DELF certification, although the specific details regarding the institution and date are not provided. Additionally, Valentina completed a certification titled "Design and Interpretation of Clinical Trials" from JOHN HOPKINS UNIVERSITY. No information regarding the month and year of obtaining this certification is given.